High-fat diet stimulates IL-1 type I receptor-mediated inflammatory signaling in the skeletal muscle of mice

Molecular Nutrition and Food Research

Volumn 54, Issue 7, 2010, Pages 1014-1020

  Kim, Seung Jin ^a   Choi, Youngshim ^a   Jun, Hye Seung ^a   Kim, Bo Min ^b   Na, Hye Kyung ^b   Surh, Young Jun ^b   Park, Taesun ^a  

^a Yonsei University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

IL 1 type I receptor; Inhibitor of k cyrillic B kinase; Metaflammation; MyD88; Nuclear factor k cyrillic B

Indexed keywords

I KAPPA B; I KAPPA B KINASE; IKAPPABETA PROTEIN, MOUSE; IKBKB PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR TYPE I; IRAK4 PROTEIN, MOUSE; MAP KINASE KINASE KINASE 7; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL; ARTICLE; C57BL MOUSE; ENZYMOLOGY; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; MALE; METABOLISM; MOUSE; OBESITY; RANDOMIZATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; DIETARY FATS; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYELOID DIFFERENTIATION FACTOR 88; OBESITY; RANDOM ALLOCATION; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS;

EID: 77954626079     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800512     Document Type: Article

References (29)

1. Boden, G., She, P., Mozzoli, M., Cheung, P. et al., Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54, 3458-3465.
2. Ajuwon, K. M., Spurlock, M. E., Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J. Nutr. 2005, 735, 1841-1846.
3. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
4. Kahn, B. B., Flier, J. S., Obesity and insulin resistance. J. Clin. Invest. 2000, 706, 473-481.
5. Wellen, K. E., Hotamisligil, G. S., Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 772, 1785-1788.
6. Juge-Aubry, C. E., Somm, E., Chicheportiche, R., Burger, D. etal., Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J. Clin. Endocrinol. Metab. 2004, 89, 2652-2658.
7. Bunout, D., Munoz, C., Lopez, M., de la Maza, M. P. et al., Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. Am. J. Clin. Nutr. 1996, 63, 373-376.
8. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I. et al., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 776, 3015-3025.
9. Bastard, J. P., Maachi, M., Van Nhieu, J. T., Jardel, C. et al., Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 2002, 87, 2084-2089.
10. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., Spiegelman, B. M., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95, 2409-2415.
11. Dinarello, C. A., Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 1998, 76, 457-499.
12. Kawai, T., Akira, S., TLR signaling. Cell Death Differ. 2006, 73, 816-825.
13. Schauvliege, R., Janssens, S., Beyaert, R., Pellino proteins: novel players in TLR and IL-1R signalling. J. Cell. Mol. Med. 2007, 77, 453-461.
14. Itani, S. I., Ruderman, N. B., Schmieder, F., Boden, G., Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and Ikap-paB-alpha. Diabetes 2002, 57, 2005-2011.
15. Sinha, S., Perdomo, G., Brown, N. F., O'Doherty, R. M., Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J. Biol. Chem. 2004, 279, 41294-41301.
16. Weigert, C., Brodbeck, K., Staiger, H., Kausch, C. et al., Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J. Biol. Chem. 2004, 279, 23942-23952.
17. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method forthe isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
18. Chun, K. S., Keum, Y. S., Han, S. S., Song, Y. S. et al., Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003, 24, 1515-1524.
19. Akira, S., Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511.
20. Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R. et al., Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 2004, 279, 16971-16979.
21. Song, M. J., Kim, K. H., Yoon, J. M., Kim, J. B., Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 2006, 346, 739-745.
22. Tsukumo, D. M., Carvalho-Filho, M. A., Carvalheira, J. B., Prada, P. O. et al., Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56, 1986-1998.
23. Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N., O'Doh-erty, R. M., Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 2008, 57, 336-346.
24. Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 2006, 724, 783-801.
25. Muller, S. D., Muller, M. R., Huber, M., Esche Uv, U. et al., Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties. Int. Immunopharmacol. 2004, 4, 1287-1300.
26. Lee, J. Y., Hwang, D. H., The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol. Cells 2006, 27, 174-185.
27. Vitseva, O. I., Tanriverdi, K., Tchkonia, T. T., Kirkland, J. L. et al., Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 76, 932-937.
28. Reyna, S. M., Ghosh, S., Tantiwong, P., Meka, C. S. et al., Elevated TLR4 expression and signaling in muscle from insulin resistant subjects. Diabetes 2008, 57, 2595-2602.
29. Takaoka, A., Yanai, H., Kondo, S., Duncan, G. et al., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005, 434, 243-249.